These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3792940)

  • 21. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of sex and hormonal status on the physiological response to acute psychosocial stress.
    Kajantie E; Phillips DI
    Psychoneuroendocrinology; 2006 Feb; 31(2):151-78. PubMed ID: 16139959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The action of hormonal steroids on the hypothalamo-pituitary-ovarian axis.
    Pincus G
    Arch Anat Microsc Morphol Exp; 1967; 56(3):475-85. PubMed ID: 5615175
    [No Abstract]   [Full Text] [Related]  

  • 24. Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function.
    Tirelli A; Cagnacci A; Volpe A
    Contraception; 2008 May; 77(5):328-32. PubMed ID: 18402847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensibility of pituitary, gonadal and thyroid function in adolescence without and after hormonal contraception.
    Rey-stocker I; Zufferey MM; Lemarchand Mth ; Rais M
    Contracept Fertil Sex (Paris); 1979 Jun; 7(6):419-40. PubMed ID: 12261224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triphasic pills: variability of endocrine parameters and of sex steroid-binding globulins.
    Pasinetti E; Falsetti L
    Acta Eur Fertil; 1993; 24(2):67-70. PubMed ID: 8171924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U; Dubois M
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormonal contraception. Mechanism of effect and usefulness].
    Bjoro K
    Tidsskr Nor Laegeforen; 1969 Sep; 89(18):1426-30. PubMed ID: 5376304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pros and cons of triphasic oral contraception].
    Berdah J
    Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1205-10. PubMed ID: 12267512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The stress system in depression and neurodegeneration: focus on the human hypothalamus.
    Bao AM; Meynen G; Swaab DF
    Brain Res Rev; 2008 Mar; 57(2):531-53. PubMed ID: 17524488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothalamic regulation of FSH and LH secretion.
    Schally AV
    Res Reprod; 1970 Jul; 2(4):2-3. PubMed ID: 12254980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadotropin-releasing hormone and its clinical applications.
    Loucopoulos A; Ferin M
    Obstet Gynecol Annu; 1984; 13():275-88. PubMed ID: 6326010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restovar--new low-dose, combined, oral contraceptive. Effects on serum proteins, free testosterone and clinical efficacy.
    Cullberg G; Adelgaard J; Andersen JN; Andersen ES; Berg H; Bergink EW; Buhl G; Pedersen JH; Poulsen L
    Contracept Deliv Syst; 1984 Apr; 5(2):97-104. PubMed ID: 12266201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of clinical studies with natural and synthetic luteinizing hormone-releasing hormone in man.
    Kastin AJ; Schally AV; Zarate A; Arimura A; Gonzalez-Barcena D; Medeiros-Neto CA; Schalch DS
    Isr J Med Sci; 1974 Oct; 10(10):1305-13. PubMed ID: 4611964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The problem of modifying X-chromatin frequency using hormonal contraceptives].
    Meinhold P; Sommer K; Hoppe H; Klinger G
    Zentralbl Gynakol; 1975; 97(11):674-8. PubMed ID: 1189759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma sex hormone binding globulin and oestrogen therapy [proceedings].
    Jequier AM; Pogmore JR; Birmingham AT
    Br J Pharmacol; 1978 Nov; 64(3):456P. PubMed ID: 568972
    [No Abstract]   [Full Text] [Related]  

  • 38. [The menstrual cycle].
    Drapier-Faure E
    Soins Gynecol Obstet Pueric Pediatr; 1986 May; (60):3-6. PubMed ID: 3641415
    [No Abstract]   [Full Text] [Related]  

  • 39. Sex, hormones and the brain.
    van Lunsen RH; Laan E
    Eur J Contracept Reprod Health Care; 1997 Dec; 2(4):247-51. PubMed ID: 9678081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Control of the menstrual cycle].
    Haller U
    Gynakol Rundsch; 1986; 26 Suppl 1():1-6. PubMed ID: 3792940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.